Aktienkurs
1,215.80
Täglich Wechseln
13.40 1.11%
Monatlich
-8.24%
Jährlich
-14.11%
Q2 Prognose
1,166.41




Dy Veränderung Datum
Arca Biopharma 0 0 2025-03
Bio Path 0 0 2025-03
Brainstorm Cell Therapeutics 0 0 2025-03
Capricor Therapeutics 0 0 2025-03
Cara Therapeutics 0 0 2025-03
Cipla 0.86 0 2025-12
Dr.Reddys Laboratories 0.63 0.02 2025-12
Esperion Therapeutics 0 0 2025-03
Infinity Pharmaceuticals 0 0 2023-06
Minerva Neurosciences 0 0 2025-03
Nektar Therapeutics 0 0 2025-03
Sangamo BioSciences 0 0 2025-03
Sun Pharmaceuticals 1 0.05 2025-09
TherapeuticsMD 0 0 2025-03
UPL 0.76 0.16 2025-12